Sign In
Buy PBYI
$8.04
+0.380 (+4.96%)
At Close: Jun 23, 2026
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:05pm, Friday, 07'th Nov 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on November 5, 2025, the Compensation Committee of Puma's Board of Directors approved
Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call Transcript
01:16pm, Friday, 07'th Nov 2025
Puma Biotechnology, Inc. ( PBYI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Mariann Ohanesian - Senior Director of Investor Relations Alan Auerbach - Founder, Chairman, P
PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised
11:56am, Friday, 07'th Nov 2025
Puma Biotechnology beats third-quarter estimates for earnings and revenues and lifts its 2025 outlook on stronger Nerlynx sales.
Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates
07:01pm, Thursday, 06'th Nov 2025
Puma Biotech (PBYI) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.45 per share a year ago.
Puma Biotechnology Reports Third Quarter 2025 Financial Results
04:05pm, Thursday, 06'th Nov 2025
LOS ANGELES--(BUSINESS WIRE)--On 11/6/26, Puma Biotechnology issued its financials for Q3-2025 and hosted a conference to discuss operating results.
15,168 Shares in Puma Biotechnology, Inc. $PBYI Bought by Ethic Inc.
04:11am, Saturday, 01'st Nov 2025
Ethic Inc. acquired a new position in Puma Biotechnology, Inc. (NASDAQ: PBYI) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
04:10pm, Thursday, 23'rd Oct 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will issue financials and host a conference call on Nov. 6, 2025 to discuss its results for the third quarter of 2025.
3 High-Flying Stocks Under $10 to Buy Hand Over Fist Right Now
10:46am, Tuesday, 07'th Oct 2025
There's a small portion of my portfolio I allocate toward companies I'd put in the “higher risk” bucket.
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:21pm, Thursday, 02'nd Oct 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported the grant of one inducement award to a new hire in Sept. 2025, as required by Nasdaq Listing Rule 5635(c)(4).
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:25pm, Thursday, 04'th Sep 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that on September 2, 2025, the Compensation Committee of Puma's Board of Directors approve
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04:07pm, Tuesday, 02'nd Sep 2025
LOS ANGELES--(BUSINESS WIRE)--On 9/8/25, Puma Biotechnology CEO and President Alan Auerbach will present a company overview at the H.C. Wainwright Global Investment Conference.
Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:56am, Monday, 01'st Sep 2025
Puma Biotech (PBYI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
10:40am, Thursday, 28'th Aug 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
10:40am, Tuesday, 12'th Aug 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?
10:16am, Tuesday, 12'th Aug 2025
Puma Biotech (PBYI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
